Linked Data API

Show Search Form

Search Results

800902
star this property registered interest true more like this
star this property date less than 2017-12-05more like thismore than 2017-12-05
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Drugs: Misuse more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to tackle opioid abuse in the homeless community. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 117461 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-12-13more like thismore than 2017-12-13
star this property answer text <p>The Government is investing £16 billion over the Spending Review period for local authorities (LAs) to spend on public health. LAs are responsible for making decisions on how to spend their local allocation but the public health grant conditions make it clear that they must have regard for the need to improve the take up of, and outcomes from, their drug and alcohol misuse treatment services. Public Health England guidance, developed with drug service providers, promotes the need for local authorities, commissioners and healthcare providers to work together to create systems and pathways that enable people who use drugs, including those who experience homelessness, to access services.</p> more like this
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2017-12-13T14:07:33.107Zmore like thismore than 2017-12-13T14:07:33.107Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
993776
star this property registered interest true more like this
star this property date less than 2018-10-23more like thismore than 2018-10-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Mortality Rates more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether his Department plans on publishing premature mortality data at sustainability and transformation partnership and local authority level. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 182887 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-10-31more like thismore than 2018-10-31
star this property answer text <p>Public Health England publishes premature morality data for English local authorities through Local Authority Health Profiles. There are currently no plans for premature mortality data to be published at sustainability and transformation partnership level.</p> more like this
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-10-31T14:21:05.563Zmore like thismore than 2018-10-31T14:21:05.563Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
781369
star this property registered interest false more like this
star this property date less than 2017-10-31more like thismore than 2017-10-31
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Public Health: Costs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps the Government has taken to assess the (a) cost and (b) economic productivity to the public purse of (i) alcohol misuse, (ii) obesity and (iii) viral hepatitis. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 110669 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-11-07more like thismore than 2017-11-07
star this property answer text <p>The Government wants everyone to be able to make healthier choices, regardless of their circumstances, and to minimise the risk and impact of illness. A range of action is being taken to do this and in particular on the three areas identified:</p><p> </p><p>- To tackle alcohol misuse we are preventing below cost selling, tightening the rules on irresponsible promotions and introducing new powers to deal with anti-social behaviour. Local authorities are supported by Public Health England in the commissioning of high quality, evidence based treatment services for their local population’s needs.</p><p>- In addition, the United Kingdom Chief Medical Officers have produced new low risk drinking guidelines which provide the public with the latest information about the health risks of different levels and patterns of drinking. The guidelines enable people to make informed choices about their drinking.</p><p>- Tackling childhood obesity is a priority for this Government. We launched “Childhood Obesity: A Plan for Action” in August 2016. Our world-leading plan will help children and families to recognise and make healthier choices and be more active. Many of the key commitments in our plan will have an impact on tackling obesity across all age groups. These include the soft drinks industry levy and sugar reduction programme, which will reduce the amount of sugar we all consume.</p><p>- A copy of “Childhood Obesity: A Plan for Action” is available at:</p><p><a href="http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/546588/Childhood_obesity_2016__2__acc.pdf" target="_blank">www.gov.uk/government/uploads/system/uploads/attachment_data/file/546588/Childhood_obesity_2016__2__acc.pdf</a></p><p>- The National Strategic Group on Viral Hepatitis is a Public Health England supported, cross-agency expert group on viral hepatitis with external membership from academia, NHS England, local government, clinical commissioning groups, patient representative groups and other organisations, to provide strategic direction and advice around viral hepatitis. The strategy group aims to help reduce the incidence, prevalence and consequences of infection from the viral hepatitis in England.</p>
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2017-11-07T15:05:50.56Zmore like thismore than 2017-11-07T15:05:50.56Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
810495
star this property registered interest false more like this
star this property date less than 2017-12-21more like thismore than 2017-12-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to ensure that it has adequate medical importation and exportation customs expertise after the UK leaves the EU. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 120841 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-01-11more like thismore than 2018-01-11
star this property answer text <p>Maintaining continuity of medicine supply is a key part of ensuring everyone has continued access to the medicines they need on day one of the United Kingdom’s exit from the European Union and thereafter. The UK is fully committed to continuing the close working relationship with our European partners in the interests of public health and safety; and will seek to ensure that cross-border trade with the EU is as frictionless as possible for the benefit of patients in both the EU and the UK. This will be part of the broader negotiations of the UK’s future relations with the EU and the Department will continue to work closely with Her Majesty’s Revenue and Customs during and after the negotiation period.</p> more like this
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-01-11T15:13:40.343Zmore like thismore than 2018-01-11T15:13:40.343Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
810496
star this property registered interest false more like this
star this property date less than 2017-12-21more like thismore than 2017-12-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to ensure that patient access to medicines currently available in the UK is maintained after the UK leaves the EU. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 120842 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-01-11more like thismore than 2018-01-11
star this property answer text <p>The Prime Minister has made clear that a key priority through the negotiations will be to ensure that the United Kingdom remains one of the best places in the world for science and innovation. In the negotiations, the Government will discuss with the European Union and Member States how best to continue cooperation in the field of medicines regulation in the best interests of both the UK and the EU. Our aim is to ensure that patients in the UK and across the EU continue to be able to access the best and most innovative medicines and be assured that their safety is protected through the strongest regulatory framework and sharing of data.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and the National Health Service have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p>
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property grouped question UIN
120845 more like this
120846 more like this
star this property question first answered
less than 2018-01-11T15:35:19.423Zmore like thismore than 2018-01-11T15:35:19.423Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
810499
star this property registered interest false more like this
star this property date less than 2017-12-21more like thismore than 2017-12-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Clinical Trials more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what assessment he has made of effect of the UK leaving the EU on patients involved in EU clinical trails. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 120845 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-01-11more like thismore than 2018-01-11
star this property answer text <p>The Prime Minister has made clear that a key priority through the negotiations will be to ensure that the United Kingdom remains one of the best places in the world for science and innovation. In the negotiations, the Government will discuss with the European Union and Member States how best to continue cooperation in the field of medicines regulation in the best interests of both the UK and the EU. Our aim is to ensure that patients in the UK and across the EU continue to be able to access the best and most innovative medicines and be assured that their safety is protected through the strongest regulatory framework and sharing of data.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and the National Health Service have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p>
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property grouped question UIN
120842 more like this
120846 more like this
star this property question first answered
less than 2018-01-11T15:35:19.5Zmore like thismore than 2018-01-11T15:35:19.5Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
810500
star this property registered interest false more like this
star this property date less than 2017-12-21more like thismore than 2017-12-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Clinical Trials: Rare Diseases more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department taking to ensure access to European clinical trails for the treatment of rare diseases by UK patients after the UK has left the EU. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 120846 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-01-11more like thismore than 2018-01-11
star this property answer text <p>The Prime Minister has made clear that a key priority through the negotiations will be to ensure that the United Kingdom remains one of the best places in the world for science and innovation. In the negotiations, the Government will discuss with the European Union and Member States how best to continue cooperation in the field of medicines regulation in the best interests of both the UK and the EU. Our aim is to ensure that patients in the UK and across the EU continue to be able to access the best and most innovative medicines and be assured that their safety is protected through the strongest regulatory framework and sharing of data.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and the National Health Service have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p>
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property grouped question UIN
120842 more like this
120845 more like this
star this property question first answered
less than 2018-01-11T15:35:19.58Zmore like thismore than 2018-01-11T15:35:19.58Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
818651
star this property registered interest false more like this
star this property date less than 2018-01-08more like thismore than 2018-01-08
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Innovative Medicines and Medical Technology Review more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, with reference to the Government response to the Accelerated Access Review published in November 2017, what plans his Department has to streamline existing routes to market for medical technologies, devices and diagnostics. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 121415 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-01-16more like thismore than 2018-01-16
star this property answer text <p>We are introducing a new Accelerated Access Pathway, to streamline regulatory and market access decisions, getting breakthrough products that we believe will be truly transformative to patients more quickly. A new Accelerated Access Collaborative (AAC) chaired by Sir Andrew Witty, will develop and own the Accelerated Access Pathway which will be operational from April 2018. All products including medical technologies, devices and diagnostics will be eligible for selection. In addition to the new Pathway, the AAC will also make recommendations to the Government and its partners about opportunities to further streamline existing routes to market.</p> more like this
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-01-16T12:04:46.697Zmore like thismore than 2018-01-16T12:04:46.697Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
819796
star this property registered interest false more like this
star this property date less than 2018-01-10more like thismore than 2018-01-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medical Treatments: Innovation more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the number of technology appraisals on medical technologies, devices and diagnostics that the National Institute for Health and Care Excellence undertakes over the next five years. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 121868 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-01-19more like thismore than 2018-01-19
star this property answer text <p>From April 2018 we are introducing a new Accelerated Access Pathway (AAP), to streamline regulatory and market access decisions, getting breakthrough and transformative products to patients more quickly. All products including medical technologies, devices and diagnostics will be eligible for selection. The AAP will complement existing activity and involve a significant role for the National Institute for Health and Care Excellence (NICE), building on existing momentum such as NICE's Fast Track Appraisal Process.</p> more like this
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-01-19T11:33:14.337Zmore like thismore than 2018-01-19T11:33:14.337Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this
819797
star this property registered interest false more like this
star this property date less than 2018-01-10more like thismore than 2018-01-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medical Treatments: Innovation more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans his Department has to ensure a funding requirement is placed on medical technologies, devices and diagnostics that receive a positive technology appraisal from the National Institute for Health and Care Excellence. more like this
star this property tabling member constituency East Kilbride, Strathaven and Lesmahagow remove filter
star this property tabling member printed
Dr Lisa Cameron more like this
star this property uin 121869 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-01-19more like thismore than 2018-01-19
star this property answer text <p>A funding requirement automatically applies to any intervention, including medical technologies, devices and diagnostics, recommended in technology appraisal guidance issued by the National Institute for Health and Care Excellence, in line with the NHS Constitution.</p> more like this
star this property answering member constituency Winchester remove filter
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-01-19T11:29:37.253Zmore like thismore than 2018-01-19T11:29:37.253Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4412
unstar this property label Biography information for Dr Lisa Cameron more like this